Tecvayli: First FDA-Approved Bispecific Antibody for Relapsed/Refractory Multiple Myeloma
Kim Navarrete, MSN, APRN, FNP-C, OCN, and Nilesh Kalariya, PhD, AGPCNP-BC, AOCNP Multiple myeloma (MM) is a hematologic malignancy associated with the clonal proliferation of plasma cells. Despite decades of…